July 9, 2025 · Form 4 insider transaction
Onyia Jude bought 59,819 shares of Neurocrine Biosciences, Inc. at $84.74 per share, a transaction worth $5.07M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.